Retail pharmacy drug sales in 13 major markets during the 12 months to February 2008 have reached $424.9 billion, reports IMS Health's Retail Drug Monitor. This is a rise of 7.5% compared with $395.4 billion for the year ended March 2007, continuing a slight slowdown from the start of the year (Marketletter April 21). Since the last report, Canada has caught up with Italy, the latter being the only market to experience a contraction. The fastest-growing region remains Australia and New Zealand, with a combined market of $7.5 billion, up 11%.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
| Headless Content Management with Blaze